• Skip to primary navigation
  • Skip to main content
Kinderhook Industries

Kinderhook Industries

  • Investment Philosophy
  • Team
  • Our Portfolio
  • Portfolio News
  • LP Portal

Life Line Screening, a Unique Prevention and Wellness Platform, Announces Matt Miller as CEO

Life Line Screening, a Unique Prevention and Wellness Platform, Announces Matt Miller as CEO

February 22, 2023

Austin, TX – Life Line Screening (“Life Line” or the “Company”), a portfolio company of Kinderhook Industries, LLC (“Kinderhook”), announced today that healthcare executive Matt Miller has been appointed Chief Executive Officer of the Company.

Before joining Life Line, Mr. Miller was most recently the Chief Executive Officer and Co-Founder of StudyKIK, a former Kinderhook portfolio company which was sold to Syneos Health (NYSE: SYNH) in September 2021. StudyKIK focused on offering the clinical trial industry the most innovative methods of enrollment and data analytics, lifting the veil over patient recruitment return on investment. During his tenure, Mr. Miller was instrumental in developing a technology platform that improved quality and accelerated enrollment timelines in clinical trials. Prior to StudyKIK, Mr. Miller held leadership roles at WCCT Global, a multi-site full-service global contract research organization, where he was responsible for managing patient recruitment campaigns for clinical trials. Mr. Miller holds a BA from California State University – Fullerton.

“Matt Miller possesses impressive industry knowledge, operational expertise, and a forward-thinking mentality that the Board believes is imperative to lead Life Line Screening into the future,” said Mark Hanley, Executive Chairman of Life Line Screening. “Matt Miller’s demonstrated leadership ability and extensive healthcare experience make him a perfect fit to lead Life Line through its next phase of growth and continuous improvement of service.”

“I am thrilled to join and lead Life Line at this important time for the Company,” said Mr. Miller. “I have tremendous regard for the Company’s rich history and am extremely optimistic about its mission and direction. I look forward to working with the talented Life Line team to continue to improve the continuum of preventative care for consumers.”

“The leadership and effectiveness Matt exhibited during his five-year tenure as Chief Executive Officer at StudyKIK were exemplary, and I am excited to work with him again,” said Chris Michalik, Managing Director of Kinderhook.

For additional information about this transaction, please contact: 
Christian Michalik
Managing Director
(212) 201-6782
[email protected]
 
Michael Zoch
Managing Director
(212) 201-6785
[email protected]


About Kinderhook Industries

Founded in 2003, Kinderhook Industries, LLC is a private investment firm that manages over $5.4 billion of committed capital. We have made in excess of 375 investments and follow-on acquisitions since inception. Kinderhook’s investment philosophy is predicated on matching unique, growth-oriented investment opportunities with exceptional financial expertise and our proprietary network of operating partners. Our focus is on middle market businesses with defensible niche market positioning in the healthcare services, environmental / business services, and automotive / light manufacturing sectors. We have a track record of successfully and consistently building industry leaders.

For more information, please visit https://www.kinderhook.com


About Life Line Screening

Life Line Screening is a unique prevention and wellness platform that offers an assortment of health screening and other community-based health services. Life Line offers affordable testing services to individuals who want to take greater control of their health and wellness. The Company's mobile field teams host over 14,000 community-based pop-up screening events per year.

For more information, please visit https://www.lifelinescreening.com/

Copyright © 2023 Kinderhook Industries. All rights reserved.